Sarah J. Neering
University of Rochester Medical Center(US)University of Rochester(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Retinoids in leukemia and cellular processes, Protein Degradation and Inhibitors
Most-Cited Works
- → BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells(2013)1,365 cited
- → Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells(2001)752 cited
- → Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis(2003)209 cited
- → Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells(2013)198 cited
- → Leukemia stem cells in a genetically defined murine model of blast-crisis CML(2007)145 cited
- → Gene Sets Identified with Oncogene Cooperativity Analysis Regulate In Vivo Growth and Survival of Leukemia Stem Cells(2012)66 cited
- → Comparative genetic analysis of genomic DNA sequences of two human isolates of Tanapox virus(2007)25 cited
- → The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene(2008)21 cited
- → Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells(2012)3 cited
- → Reactive Oxygen Species (ROS) Levels Define Functional Heterogeneity in Human Leukemia Stem Cells and Represent a Critical Parameter for Therapeutic Targeting(2011)2 cited